August 26, 2009 — Intramuscular injection treatment of an antisense molecule is safe and effective in increasing dystrophin, the absence of which causes Duchenne muscular dystrophy (DMD), according to ...

Dublin, Oct. 01, 2025 (GLOBE NEWSWIRE) -- The "Antisense Oligonucleotides Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Antisense Molecule, Type of ASO Generation, ...

COLUMBUS, Ohio – A new study shows that it is possible to selectively target and block a particular microRNA that is important in liver cancer. The findings might offer a new therapy for this ...

Most scientists are fortunate if they can make one major discovery in their lifetime. Dr. Paul Zamecnik made two, each of which should have won him a Nobel Prize. Working with Dr. Mahlon Hoagland, he ...

Dantrolene improves antisense oligonucleotide mediated exon skipping efficiency. Induced exon skipping is a promising therapy for Duchenne muscular dystrophy (DMD), but current clinical trials rescue ...

After a two-decade cycle of investor embrace and rejection, partnerships won and lost, failed clinical trials, layoffs, and rebuilds, Isis Pharmaceuticals has gained approval for the first ...

Courtesy of Antisense Therapeutics Ltd. Antisense strategies use polymeric nucleic acids or nucleic acid analogs to bind to and silence specific messenger RNAs. The silencing can be caused either by ...

Biogen Idec and Isis Pharmaceuticals said today they inked their fourth collaboration in the past two years—a six-year, up-to-$320 million-plus partnership designed to develop new therapies for ...

COLUMBUS, Ohio - A new study shows that it is possible to selectively target and block a particular microRNA that is important in liver cancer. The finding might offer a new therapy for this ...

(MENAFN- GlobeNewsWire - Nasdaq) The antisense oligonucleotides market offers growth opportunities across diverse disease indications, with promising therapeutic developments for genetic, oncological, ...